- Tytuł:
- Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
- Autorzy:
- Corporate Authors:
- EMPRISE East Asia Study Group
- Źródło:
- Journal of diabetes investigation [J Diabetes Investig] 2023 Mar; Vol. 14 (3), pp. 417-428. Date of Electronic Publication: 2023 Jan 30.
- Typ publikacji:
- Meta-Analysis; Journal Article
- MeSH Terms:
-
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Cardiovascular Diseases*/chemically induced
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic useMyocardial Infarction *
Humans ; Asia, Eastern/epidemiology ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe